Home>Topics>Companies>Sanofi S.A.

Sanofi S.A.

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source

    Headlines

    Fri, 27 Mar 2015

    PARIS, March 27 (Reuters) - French drugmaker Sanofi plans to launch its new Toujeo insulin for diabetics in the United States on Monday, according to a source familiar with the matter.

  2. UPDATE 1- Sanofi test shows lixisenatide doesn't increase cardiovascular risk

    Headlines

    Thu, 19 Mar 2015

    PARIS, March 19 (Reuters) - Sanofi 's lixisenatide drug for the treatment of type 2 diabetes does not increase cardiovascular risk among high risk patients, the French drugmaker said on Thursday.

  3. Sanofi says test shows lixisenatide doesn't increase cardiovascular risk

    Headlines

    Thu, 19 Mar 2015

    PARIS, March 19 (Reuters) - Drugmaker Sanofi said its lixisenatide drug for the treatment of type 2 diabetes did not increase cardiovascular risk among high risk patients in a study it conducted.

  4. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

    Headlines

    Tue, 17 Mar 2015

    Medium 8 4 Unilever UL* 2 Wide 42.06 1.11 3.5 Medium 9 4 McDonald's MCD 3 Wide 96.35 0.98 3.4 Medium 5 1 Sanofi SNY * 4 Wide 47.07 0.86 3.4 Medium 6 2 EmersonElec EMR 4 Wide 55.26 0.8 3.3 Medium 7 1 ExxonMobil XOM 4 Wide 83

  5. CORRECTED-Sacked Sanofi boss joins PureTech board

    Headlines

    Fri, 27 Feb 2015

    PARIS, Feb 27 (Reuters) - Chris Viehbacher , sacked as chief executive of French drugs firm Sanofi last year, is to join the board of PureTech, a privately owned healthcare science and technology R&D company.

  6. Sanofi diabetes drug Toujeo wins European green light

    Headlines

    Fri, 27 Feb 2015

    LONDON, Feb 27 (Reuters) - French drugmaker Sanofi 's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared to go on sale in the United States, regulators...

  7. UPDATE 2- Sanofi's diabetes drug Toujeo gets U.S. approval, label disappoints

    Headlines

    Thu, 26 Feb 2015

    Feb 26 (Reuters) - French drugmaker Sanofi SA 's new Toujeo diabetes drug won U.S. regulatory approval, but with wording on its prescribing label that analysts say could make marketing difficult.

  8. U.S. FDA approves Sanofi's diabetes drug Toujeo

    Headlines

    Wed, 25 Feb 2015

    Feb 25 (Reuters) - U.S. health regulators on Wednesday approved Sanofi 's diabetes drug Toujeo, a more potent follow-up to the French drugmaker 's top-selling insulin product Lantus.

  9. Sanofi names CEO, cites 'capabililty to unite teams'

    Headlines

    Thu, 19 Feb 2015

    PARIS (Reuters) - French drugmaker Sanofi on Thursday named Olivier Brandicourt, a Paris-educated doctor and head of Bayer AG's healthcare arm, as its chief executive officer.

  10. UPDATE 1- Sanofi names CEO, cites 'capabililty to unite teams'

    Headlines

    Thu, 19 Feb 2015

    PARIS, Feb 19 (Reuters) - French drugmaker Sanofi on Thursday named Olivier Brandicourt, a Paris-educated doctor and head of Bayer AG's healthcare arm, as its chief executive officer.

« Prev12345Next »
Content Partners